Latest News

KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC: Konica Minolta’s Workplace Hub Awarded Managed.IT Magazine’s Editor’s Choice

Konica Minolta Business Solutions, U.S.A., Inc. is proud to announce that its Workplace Hub solution recently received the prestigious Editor’s Choice award by Managed.IT Magazine.

MIDDLESEX COUNTY REGIONAL CHAMBER OF COMMERCE: Jessica Schwartz and Adam Livow are just two of many individuals who help represent iPlay America in freehold

Jessica Schwartz, Vice President Sales & Marketing of iPlay America, and Adam Livow, Executive Chef at iPlay America, are proud employees of the iPlay America family in Freehold.

MIDDLESEX COUNTY REGIONAL CHAMBER OF COMMERCE: Be A Part of April's Networking Breakfast

Don’t miss our April Networking Breakfast, Friday, April 26 at 8:30 a.m., at one of the most well-known restaurants in the Hub City, Due Mari, 78 Albany St., New Brunswick.

KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC: Konica Minolta To Exhibit As Gold Sponsor At ALA 2019

Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) and its IT Services Division, All Covered, today announced their gold sponsorship and participation in the Association of Legal Administrators (ALA) 2019 Annual Conference & Expo in Grapevine, Texas, April 14-17.

CELGENE CORPORATION: Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Biologics License Application to U.S. FDA

Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that Celgene has submitted a Biologics License Application (BLA) for luspatercept, an erythroid maturation agent, for the treatment of adult patients with very low to intermediate risk myelodysplastic syndromes (MDS)-associated anemia who have ring sideroblasts and require red blood cell (RBC) transfusions and for the treatment of adult patients with beta-thalassemia-associated anemia who require RBC transfusions.

DAIICHI SANKYO, INC: EMA Validates Daiichi Sankyo’s Marketing Authorization Application for Pexidartinib for Treatment of Patients with TGCT, a Rare, Debilitating, Non-Malignant Tumor

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the European Medicines Agency (EMA) validated the Marketing Authorization Application (MAA) for pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT), which is associated with severe morbidity or functional limitations, and which is not amenable to improvement with surgery.

NEW JERSEY CHAMBER OF COMMERCE: Student Bill of Rights Central to New State Plan for Higher Education

Long-terms goals include making college more affordable, keeping talent in New Jersey, and giving students a stronger voice For the first time in more than 13 years, New Jersey has a plan for improving higher education in the state.

CELGENE CORPORATION: Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis

Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (RMS). Ozanimod is an oral, sphingosine 1-phosphate (S1P) receptor modulator, which binds with high affinity selectively to S1P subtypes 1 (S1P1) and 5 (S1P5).

NEW JERSEY CHAMBER OF COMMERCE: Statement on Proposed State Budget

New Jersey Chamber of Commerce Executive Vice President Michael Egenton's Statement on Proposed State Budget Following His Testimony at the Assembly Budget Committee

NYMOX PHARMACEUTICAL CORPORATION: Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC, as the Company's Director of Quality and EU Qualified Person, for all of Nymox's Chemistry, Manufacturing and Controls Operations.

CELGENE CORPORATION: Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a Marketing Authorization Application to the European Medicines Agency (EMA) for ozanimod for the treatment of adults with relapsing-remitting multiple sclerosis (RRMS).

MIDDLESEX COUNTY REGIONAL CHAMBER OF COMMERCE: The Chamber Helps Build Culture For Business Success

The Middlesex County Regional Chamber of Commerce (MCRCC) and SHRM CNJ hosted this year’s Human Resources Summit at the Rutgers Club on February 21.

NEW JERSEY CHAMBER OF COMMERCE: New Jersey Chamber of Commerce President Tom Bracken's Statement on the Governor's Budget Address

In today’s budget speech, several of Gov. Murphy’s proposals begin to steer New Jersey toward the stronger economy he envisions and that we all want.

PREVALENT: Prevalent Wins Gold for Vendor Risk Management in Cybersecurity Excellence Awards

Prevalent, Inc., the only comprehensive platform for managing third-party risk, today announced its gold-level victory in the Cybersecurity Excellence Awards, an annual competition honoring individuals and companies that demonstrate excellence, innovation and leadership in information security.

PREVALENT: Prevalent Announces New CEO, Expands Leadership Team with Creation of 3 C-Suite Positions

Prevalent, Inc., the only unified platform for managing third-party risk, today announced the appointment of Kevin Hickey as Chief Executive Officer and the creation of three new C-suite positions.

DAIICHI SANKYO, INC: Daiichi Sankyo Shifts Several Top Leaders to New Roles for Company’s Launch into its Next Growth Phase

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced senior-level organizational changes to oversee the realization of the company’s long-term vision and strategic priorities, which include delivering seven distinct new molecular entities in oncology by 2025, as well as specialty medicines that change the standard of care.

JOHNSON & JOHNSON: Johnson & Johnson to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, Feb. 28th, at Lotte New York Palace, NY.

KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC: Konica Minolta Awarded RobecoSAM Gold Class For Second Consecutive Year

Konica Minolta Business Solutions U.S.A., Inc., announced today that its Japan-based headquarters, Konica Minolta, Inc., (Konica Minolta), was awarded Gold Class by RobecoSAM.

Metro Business Network